Brian Keith Smith, MSW | |
1213 Maria Ln, Iuka, MS 38852-1135 | |
(662) 423-3332 | |
(662) 423-3331 |
Full Name | Brian Keith Smith |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 1213 Maria Ln, Iuka, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225541626 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | (Mississippi) | Secondary |
106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brian Keith Smith, MSW 1213 Maria Ln, Iuka, MS 38852-1135 Ph: (662) 423-3332 | Brian Keith Smith, MSW 1213 Maria Ln, Iuka, MS 38852-1135 Ph: (662) 423-3332 |
News Archive
The Australian Government is discussing the introduction of meditation as a means to reduce psychological trauma to children who are abused or have to sit through court sessions. The trauma that a child at risk of abuse or other legal conflicts undergoes has been long debated and often accepted as a bitter truth.
April is National Minority Health Month, and one of the most significant health issues minorities face is disproportionate rates of smoking and health-related illnesses.
Cataract surgery can benefit patients with exudative age-related macular degeneration previously treated with anti-vascular endothelial growth factors if they have been treated and are exudation-free for more than 12 months, study findings indicate.
"As explained in the ruling yesterday, the District Court's determination is only a preliminary step in the legal process that does not affect how the U.S. Patent and Trademark Office (PTO) evaluates patent applications relating to DNA-based inventions."
Inhibitex, Inc., announced today that Pfizer Inc. presented safety and immunogenicity data from a Phase 1 double-blind randomized placebo controlled study in 408 healthy volunteers of a novel three antigen Staphylococcus aureus investigational vaccine at the 21st European Congress of Clinical Microbiology and Infectious Diseases and 27th International Congress of Chemotherapy in Milan, Italy.
› Verified 4 days ago